|
Mean scores (Standard Deviation) for the MMQL-UK (PF) components for the different patient groups and controls |
||||||
| MMQL-UK (PF) |
Control (n = 296) |
Asthma (n = 37) |
Diabetes (n = 70) |
Cancer (n = 42) |
IBD (n = 56) |
Public Care (n = 71) |
|
|
||||||
| Physical Appearance |
76.9 (22.26) |
64.9 (31.8) ES 0.54 |
67.7 (25.3)* ES 0.50 |
56.8 (23.6)** ES 0.99 |
59.5 (25.8)** ES 0.83 |
69.5 (25.8) ES 0.42 |
| School Functioning |
76.2 (26.0) |
73.1 (26.5) ES 0.11 |
73.4 (25.7) ES 0.11 |
45.2 (33.9)** ES 1.02 |
68.8 (26.0) ES 0.28 |
52.0 (32.0)** ES 0.83 |
| Social Functioning |
86.4 (16.1) |
84.6 (20.3) ES 0.10 |
87.1 (16.6) ES -0.04 |
78.3 (16.9)* ES 0.50 |
83.0 (16.4) ES 0.21 |
73.5 (25.0)** ES 0.61 |
| Emotional Functioning |
69.1 (11.6) |
63.1 (13.9)* ES = 0.47 |
62.1 (13.3)** ES = 0.56 |
60.7 (11.3)** ES = 0.73 |
59.7 (16.6)** ES = 0.66 |
67.5 (18.8) ES = 0.10 |
| Physical Functioning |
86.8 (16.8) |
56.5 (28.0)** ES = 1.31 |
80.4 (18.0)* ES = 0.37 |
55.6 (29.5)** ES = 1.30 |
55.9 (27.8)** ES = 1.28 |
78.2 (20.7)** ES = 0.46 |
|
Independent samples t-test with Bonferroni correction for multiple comparisons. ** Significant at the 0.01 level. *Significant at the 0.05 level. ES = effect size: small = 0.2–0.49; moderate = 0.5–0.79; large>0.8 [26] | ||||||
Hutchings et al. Health and Quality of Life Outcomes 2008 6:19 doi:10.1186/1477-7525-6-19 |
||||||